Resistin and visfatin: regulators of insulin sensitivity, inflammation and immunity
As Aons own researchers put it, that is not just a win for patients
If youre serious about safe, proven results, the safest move is working with a provider who can prescribe the real thing
Current status: Phase 3 trials (expected to continue through 2025-2026) FDA approval timeline: Likely 2026-2027 at the earliest What needs to happen first: Complete Phase 3 trials in larger populations Gather long-term safety data FDA review and approval process Manufacturing scale-up So while the results are exciting, we're still a few years away from retatrutide being available by prescription
Key Takeaways Semaglutide doesnt directly interact with alcohol, but drinking can intensify nausea, vomiting, and dizziness
Patients often focus on physical changes, but many tell us the most meaningful improvements are better sleep, more energy, and feeling more like themselves again
